Revisiting Freund's incomplete adjuvant for vaccines in the developing world

Trends in Parasitology

Volumn 21, Issue 9, 2005, Pages 412-414

  Miller, Louis H ^a   Saul, Allan ^a   Mahanty, Siddhartha ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM POTASSIUM SULFATE; AS 02; CHOLERA VACCINE; FREUND ADJUVANT; INFLUENZA VACCINE; ISA 51; ISA 720; MALARIA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID DERIVATIVE; QS 21; TETANUS TOXOID; UNCLASSIFIED DRUG;

ABSCESS; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EMULSION; GRANULOMA; HUMAN; IMMUNOGENICITY; INFLUENZA; INJECTION SITE REACTION; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; SHORT SURVEY; TETANUS;

PLASMODIUM FALCIPARUM;

EID: 23644455974     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2005.07.005     Document Type: Article

References (20)

1. J.E. Salk The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water-in-oil emulsion Am. J. Hyg. 55 1952 439 456
2. J. Aucouturier Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines Expert Rev. Vaccines 1 2002 111 118
3. C.H. Stuart-Harris Adjuvant influenza vaccines Bull. WHO 41 1969 617 621
4. R. MacLennan Immunization against neonatal tetanus in New Guinea. Antitoxin responses of pregnant women to adjuvant and plain toxoids Bull. WHO 32 1965 683 697
5. Philippines Cholera Committee A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines. Preliminary Report Bull. WHO 32 1965 603 625
6. P.L. Alonso Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial Lancet 364 2004 1411 1420
7. A.W. Stowers Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria Infect. Immun. 70 2002 6961 6967
8. S. Singh Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoites surface protein Infect. Immun. 71 2003 6766 6774
9. A. Banzhoff A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: Results from an immunogenicity meta-analysis Gerontology 49 2003 177 184
10. E. Malkin Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria Infect. Immun. 73 2005 3677 3685
11. J.B. Robbins Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum J. Infect. Dis. 171 1995 1387 1398
12. R. Murray Mineral oil adjuvants: biological and chemical studies Ann. Allergy 30 1972 146 151
13. M.F. Barile, and C. Hardegree A cell culture assay to evaluate the toxicity of Arlacel A Proc. Soc. Exp. Biol. Med. 133 1970 222 228
14. G.W. Beebe Long-term mortality follow-up of army recruits who received adjuvant influenza virus vaccine in 1951-1953 Am. J. Epidemiol. 95 1972 337 346
15. W.F. Page Long-term follow-up of army recruits immunized with Freund's incomplete adjuvanted vaccine Vaccine Res. 2 1993 141 149
16. M.C. Hardegree, and M. Pittman Influence of antigens on release of free fatty acids from Arlacel A (mannide monooleate) Proc. Soc. Exp. Biol. Med. 123 1966 179 184
17. M.C. Hardegree, and R.L. Kirschstein The toxicity of free fatty acids and Arlacel A Ann. Allergy 26 1968 259 268
18. H. Toledo A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA720 adjuvant in non-HIV-1 infected human volunteers Vaccine 19 2001 4328 4336
19. T.N. Pullman The use of SN-10,275 in the prophylaxis and treatment of sporozoite-induced vivax malaria (Chesson strain) J. Clin. Invest. 27 1948 12 16
20. C.M. Trenholme Mefloquine (WR 142,490) in the treatment of human malaria Science 190 1975 792 794